Research to Prevent Blindness

New Findings on Blood Vessel Regulation

Gregory Schwartz, PhD, an RPB Career Development Award recipient, and his research collaborators at Northwestern University School of Medicine, recently published important discoveries related to blood vessel regulation in the journal Neuron. They identified nitric oxide-releasing amacrine cells as critical to blood vessel regulation in the retina and beyond.

The findings could impact diseases involving blood flow, such as diabetic retinopathy (DR). By detecting damage to nitric oxide-releasing amacrine cells, DR could potentially be diagnosed years earlier than is currently possible—before damage occurs. The knowledge gained through this research could even lead to new options for stroke treatment.

Read the full news story from Northwestern Medicine

top

November 27, 2018

Diabetic Retinopathy

Feature Story

Retina Disorders

stroke

Top Story

Related News: Diabetic Retinopathy, Feature Story, Retina Disorders , stroke, Top Story

Watch The Video

Research to Prevent Blindness Celebrates 60th Anniversary

For the past 60 years, RPB has funded groundbreaking research to prevent, treat and cure all conditions that damage or destroy sight.

National Eye Institute Recognizes RPB's 60th Anniversary

The NEI congratulates RPB on 60 years of accomplishments in a personal letter from the acting director.

Watch The Video

In Their Own Words: Why the RPB Career Development Awards Matter

Thank you to our donors for supporting the RPB CDA and launching more than 200 research careers!

Dr. Semenza and colleague work in his lab

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.